EIF4EBP2 and neoplasm: DT-061 also promoted rapid accumulation of faster-migrating forms of 4E-BP2 in IEC-18 and tumor cells (Figure 2, B and F, arrows), indicating that both 4E-BP1 and 4E-BP2 can be targeted with SMAPs.